Why Tempus AI, Inc. (TEM) Soared Last Week

We recently compiled a list of the Last Week’s Top 10 Stocks Post Double-Digit Gains. In this article, we are going to take a look at where Tempus AI, Inc. (NASDAQ:TEM) stands against the other stocks.

The stock market may have registered losses on Friday, but remained firmer on a week-on-week basis, with the bellwether indices continuing to track further developments from the growing trade tensions globally.

On a weekly basis, the Dow Jones was up 0.5 percent, the S&P 500 grew 1.47 percent, while the tech-heavy Nasdaq increased 2.57 percent.

Meanwhile, ten companies mirrored broader market optimism, booking as much as double-digit gains in just the last five trading days.

To come up with the list, we considered only the stocks with at least $2 billion in market capitalization and $5 million in daily trading volume.

10 AI Stocks on Latest News and Ratings

A scientist at a computer station, surrounded by a neural network of artificial intelligence code.

Tempus AI, Inc. (NASDAQ:TEM)

Tempus AI, Inc. (NASDAQ:TEM) grew its share prices by 29.7 percent week-on-week to end Friday’s trading at $89.44 apiece versus the $68.96 on February 7, as investors gobbled up shares in the company after sealing a deal with the nonprofit organization Institute for Follicular Lymphoma Innovation (IFLI).

In a statement, Tempus AI, Inc. (NASDAQ:TEM) said the partnership aims to develop targeted therapies for the disease through developing a real-world multimodal, de-identified FL data library in its data analytics platform, through which researchers may derive AI-driven insights to accelerate the development of FL treatments in an effort to improve patient outcomes.

Tempus AI, Inc. (NASDAQ:TEM) said the two parties will focus on prospectively generating multimodal FL data, particularly for POD24 patients who experience disease progression within 24 months of treatment.

Data from the National Cancer Institute as of 2024 showed that FL is most frequently diagnosed among people aged 65 to 74 and that the survival rate is currently at 89.9 percent.

Overall TEM ranks 8th on our list of last week’s top gainers. While we acknowledge the potential of TEM as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than TEM but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap.

Disclosure: None. This article is originally published at Insider Monkey.